Detalhe da pesquisa
1.
BRAF and MEK inhibitor combinations induce potent molecular and immunological effects in NRAS-mutant melanoma cells: Insights into mode of action and resistance mechanisms.
Int J Cancer
; 154(6): 1057-1072, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38078628
2.
Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19.
Am J Respir Crit Care Med
; 207(1): 38-49, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35926164
3.
Expression of DNA Methyltransferase 1 Is a Hallmark of Melanoma, Correlating with Proliferation and Response to B-Raf and Mitogen-Activated Protein Kinase Inhibition in Melanocytic Tumors.
Am J Pathol
; 190(10): 2155-2164, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32679231
4.
Comparative Analysis of the Antitumor Activity of Cis- and Trans-Resveratrol in Human Cancer Cells with Different p53 Status.
Molecules
; 26(18)2021 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34577057
5.
T-helper-1-cell cytokines drive cancer into senescence.
Nature
; 494(7437): 361-5, 2013 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23376950
6.
Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype.
Mol Cancer
; 17(1): 59, 2018 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29454361
7.
6- and 8-Prenylnaringenin, Novel Natural Histone Deacetylase Inhibitors Found in Hops, Exert Antitumor Activity on Melanoma Cells.
Cell Physiol Biochem
; 51(2): 543-556, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30458450
8.
Inhibiting HSP90 prevents the induction of myeloid-derived suppressor cells by melanoma cells.
Cell Immunol
; 327: 68-76, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29478948
9.
EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy.
J Am Acad Dermatol
; 89(5): 1072-1074, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37487833
10.
Molecular insights into melanoma brain metastases.
Cancer
; 123(S11): 2163-2175, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28543697
11.
Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1.
Exp Dermatol
; 26(7): 598-606, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28423208
12.
Circulating tumor DNA (ctDNA) in the detection of relapse in melanoma patients with adjuvant anti-PD-1 therapy.
J Dtsch Dermatol Ges
; 20(6): 867-871, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35555861
13.
Zirkulierende Tumor-DNA (ctDNA) bei der Entdeckung von Rezidiven bei Melanompatienten mit adjuvanter Anti-PD-1-Therapie.
J Dtsch Dermatol Ges
; 20(6): 867-871, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35711040
14.
Molecular mechanisms of pharmacological doses of ascorbate on cancer cells.
Wien Med Wochenschr
; 165(11-12): 251-7, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26065536
15.
Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy.
J Exp Clin Cancer Res
; 43(1): 30, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263136
16.
Relevant Membrane Transport Proteins as Possible Gatekeepers for Effective Pharmacological Ascorbate Treatment in Cancer.
Antioxidants (Basel)
; 12(4)2023 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37107291
17.
Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma.
Cancers (Basel)
; 15(23)2023 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38067230
18.
High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma.
Cells
; 12(2)2023 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36672190
19.
PARP Inhibitors Effectively Reduce MAPK Inhibitor Resistant Melanoma Cell Growth and Synergize with MAPK Inhibitors through a Synthetic Lethal Interaction In Vitro and In Vivo.
Cancer Res Commun
; 3(9): 1743-1755, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37674529
20.
Identification of stage I/II melanoma patients at high risk for recurrence using a model combining clinicopathologic factors with gene expression profiling (CP-GEP).
Eur J Cancer
; 182: 155-162, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36739215